{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:45:45Z","timestamp":1780335945731,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.intimp.2013.08.021","type":"journal-article","created":{"date-parts":[[2013,9,22]],"date-time":"2013-09-22T08:47:31Z","timestamp":1379839651000},"page":"768-773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of TNF antagonism by etanercept and dexamethasone on airway epithelium and remodeling in an experimental model of asthma"],"prefix":"10.1016","volume":"17","author":[{"given":"Ozge","family":"Yilmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Alper","family":"Bagriyanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Firinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muge","family":"Kiray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Turkeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozkan","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.08.021_bb0005","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3904\/kjim.2011.26.4.367","article-title":"Recent advances in mechanisms and treatments of airway remodeling in asthma: a message from the bench side to the clinic","volume":"26","author":"Cho","year":"2011","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.intimp.2013.08.021_bb0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/intimm\/dxr032","article-title":"Infliximab alleviates inflammation and ex vivo airway hyperreactivity in asthmatic E3 rats","volume":"23","author":"Cai","year":"2011","journal-title":"Int Immunol"},{"key":"10.1016\/j.intimp.2013.08.021_bb0015","doi-asserted-by":"crossref","first-page":"50s","DOI":"10.1183\/09031936.01.00229701","article-title":"Cytokines in chronic obstructive pulmonary disease","volume":"34","author":"Chung","year":"2001","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.intimp.2013.08.021_bb0020","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa050580","article-title":"Evidence of a role of tumor necrosis factor alpha in refractory asthma","volume":"354","author":"Berry","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2013.08.021_bb0025","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.intimp.2011.02.024","article-title":"Chronic OVA allergen challenged TNF p55\/p75 receptor deficient mice have reduced airway remodeling","volume":"11","author":"Cho","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2013.08.021_bb0030","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1183\/09031936.00063510","article-title":"Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial","volume":"37","author":"Holgate","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.intimp.2013.08.021_bb0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/thx.53.10.849","article-title":"An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen","volume":"53","author":"Temelovski","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2013.08.021_bb0040","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.rmed.2005.02.031","article-title":"Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation","volume":"99","author":"Rouhani","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.intimp.2013.08.021_bb0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jaci.2007.10.028","article-title":"Targeting TNF-alpha: a novel therapeutic approach for asthma","volume":"121","author":"Brightling","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.08.021_bb0050","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1164\/rccm.200601-072OC","article-title":"The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma","volume":"174","author":"Erin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2013.08.021_bb0055","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/thx.2007.086314","article-title":"The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: A double blind, randomised, placebo controlled trial","volume":"63","author":"Morjaria","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2013.08.021_bb0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1164\/rccm.200809-1512OC","article-title":"A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma","volume":"179","author":"Wenzel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2013.08.021_bb0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaci.2011.06.002","article-title":"What effect does asthma treatment have on airway remodeling? Current perspectives","volume":"128","author":"Durrani","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.08.021_bb0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1465-9921-13-11","article-title":"Is low dose inhaled corticosteroid therapy as effective for inflammation and remodeling in asthma? A randomized, parallel group study","volume":"13","author":"Baraket","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.intimp.2013.08.021_bb0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/thorax.57.4.309","article-title":"Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma","volume":"57","author":"Ward","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2013.08.021_bb0080","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1046\/j.1365-2222.1998.00277.x","article-title":"Inhaledcorticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma","volume":"28","author":"Hoshino","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.intimp.2013.08.021_bb0085","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jaci.2005.07.029","article-title":"Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide","volume":"116","author":"Bergeron","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.08.021_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00408-006-0007-2","article-title":"The effect of inhaled budesonide and formoterol on bronchial remodeling and HRCT features in young asthmatics","volume":"185","author":"Capraz","year":"2007","journal-title":"Lung"},{"key":"10.1016\/j.intimp.2013.08.021_bb0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4049\/jimmunol.169.1.407","article-title":"Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells","volume":"169","author":"Lordan","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.08.021_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-2478(02)00183-9","article-title":"Fibroblast-eosinophil interaction: modulation of adhesion molecules expression and chemokine release by human fetal lung fibroblasts in response to IL-4 and TNF-alpha","volume":"84","author":"Sabatini","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1016\/j.intimp.2013.08.021_bb0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.phrs.2009.12.001","article-title":"The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells","volume":"61","author":"Goto","year":"2010","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.intimp.2013.08.021_bb0110","doi-asserted-by":"crossref","first-page":"L290","DOI":"10.1152\/ajplung.00367.2007","article-title":"Role of CD38 in TNF-alpha-induced airway hyperresponsiveness","volume":"294","author":"Guedes","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.intimp.2013.08.021_bb0115","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2011.01022.x","article-title":"Airway smooth muscle and immunomodulation in acute exacerbations of airway disease","volume":"242","author":"Koziol-White","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.intimp.2013.08.021_bb0120","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.imbio.2007.12.002","article-title":"Essential role of IFNbeta and CD38 in TNFalpha-induced airway smooth muscle hyper-responsiveness","volume":"213","author":"Jain","year":"2008","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2013.08.021_bb0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1513\/pats.200705-060VS","article-title":"Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathways","volume":"5","author":"Tliba","year":"2008","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.intimp.2013.08.021_bb0130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1183\/09031936.00058907","article-title":"Mast cell-derived tumour necrosis factor is essential for allergic airway disease","volume":"31","author":"Reuter","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.intimp.2013.08.021_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3858\/emm.2011.43.1.004","article-title":"Mast cells play a key role in Th2 cytokine-dependent asthma model through production of adhesion molecules by liberation of TNF-\u03b1","volume":"43","author":"Chai","year":"2011","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.intimp.2013.08.021_bb0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.imlet.2007.06.010","article-title":"Modulation of human lung fibroblast functions by ciclesonide: evidence for its conversion into the active metabolite desisobutyryl-ciclesonide","volume":"112","author":"Boero","year":"2007","journal-title":"Immunol Lett"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913003421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913003421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T19:53:18Z","timestamp":1539373998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913003421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1567576913003421"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.08.021","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of TNF antagonism by etanercept and dexamethasone on airway epithelium and remodeling in an experimental model of asthma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}